1-215741541-GAA-GAAA
Position:
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP6_Very_StrongBA1
The NM_206933.4(USH2A):c.11549-5_11549-4insT variant causes a splice region, splice polypyrimidine tract, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0432 in 928,684 control chromosomes in the GnomAD database, including 2 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.00094 ( 1 hom., cov: 32)
Exomes 𝑓: 0.051 ( 1 hom. )
Consequence
USH2A
NM_206933.4 splice_region, splice_polypyrimidine_tract, intron
NM_206933.4 splice_region, splice_polypyrimidine_tract, intron
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.396
Genes affected
USH2A (HGNC:12601): (usherin) This gene encodes a protein that contains laminin EGF motifs, a pentaxin domain, and many fibronectin type III motifs. The protein is found in the basement membrane, and may be important in development and homeostasis of the inner ear and retina. Mutations within this gene have been associated with Usher syndrome type IIa and retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -16 ACMG points.
BP6
Variant 1-215741541-G-GA is Benign according to our data. Variant chr1-215741541-G-GA is described in ClinVar as [Benign]. Clinvar id is 198307.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAdExome4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.0617 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
USH2A | NM_206933.4 | c.11549-5_11549-4insT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000307340.8 | NP_996816.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.11549-5_11549-4insT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_206933.4 | ENSP00000305941 | P1 | |||
USH2A | ENST00000674083.1 | c.11549-5_11549-4insT | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENSP00000501296 |
Frequencies
GnomAD3 genomes AF: 0.000931 AC: 129AN: 138634Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
129
AN:
138634
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0572 AC: 6751AN: 118084Hom.: 0 AF XY: 0.0557 AC XY: 3518AN XY: 63212
GnomAD3 exomes
AF:
AC:
6751
AN:
118084
Hom.:
AF XY:
AC XY:
3518
AN XY:
63212
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0507 AC: 40031AN: 789990Hom.: 1 Cov.: 33 AF XY: 0.0506 AC XY: 19779AN XY: 391068
GnomAD4 exome
AF:
AC:
40031
AN:
789990
Hom.:
Cov.:
33
AF XY:
AC XY:
19779
AN XY:
391068
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000937 AC: 130AN: 138694Hom.: 1 Cov.: 32 AF XY: 0.00108 AC XY: 72AN XY: 66854
GnomAD4 genome
AF:
AC:
130
AN:
138694
Hom.:
Cov.:
32
AF XY:
AC XY:
72
AN XY:
66854
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | clinical testing | GeneDx | Aug 10, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Usher syndrome type 2A Benign:2
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Benign, no assertion criteria provided | clinical testing | Natera, Inc. | Sep 25, 2019 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Aug 29, 2014 | - - |
Retinitis pigmentosa 39 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at